Luigi Vitagliano Selected Research

Fructose-Bisphosphate Aldolase (Aldolase)

12/2010	Hereditary fructose intolerance: functional study of two novel ALDOB natural variants and characterization of a partial gene deletion.
1/2005	Unraveling the structural and functional features of an aldolase A mutant involved in the hemolytic anemia and severe rhabdomyolysis reported in a child.
12/2004	Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene.
5/2004	Human aldolase A natural mutants: relationship between flexibility of the C-terminal region and enzyme function.
11/2002	Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigi Vitagliano Research Topics

Disease

6	Neoplasms (Cancer) 07/2021 - 09/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2002
4	Pathologic Processes 02/2022 - 05/2011
4	Leukemia 02/2022 - 12/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2021 - 01/2013
3	Fructose Intolerance (Intolerance, Fructose) 12/2010 - 11/2002
2	Medulloblastoma 02/2022 - 02/2010
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2021 - 12/2019
2	Obesity 01/2021 - 08/2018
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Insulin Resistance 09/2017 - 05/2016
2	Tuberculosis (Tuberculoses) 02/2016 - 06/2013
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2013 - 02/2008
2	Amyloid Plaque 01/2013 - 12/2008
2	Hemolytic Anemia 01/2005 - 05/2004
1	Carcinogenesis 02/2022
1	Breast Neoplasms (Breast Cancer) 02/2022
1	Hyperargininemia 10/2020
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Neuroblastoma 09/2015
1	Latent Tuberculosis 06/2013
1	Blindness (Hysterical Blindness) 12/2011
1	Choroideremia 12/2011
1	Metabolic Diseases (Metabolic Disease) 12/2010
1	Glioma (Gliomas) 02/2010
1	Neuralgia (Stump Neuralgia) 03/2008
1	Rhabdomyolysis 01/2005
1	Arthrogryposis 05/2004

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 02/2022 - 12/2008
5	Fructose-Bisphosphate Aldolase (Aldolase)IBA 12/2010 - 11/2002
4	Peptides (Polypeptides)IBA 01/2021 - 03/2008
3	AntigensIBA 01/2021 - 01/2021
2	Potassium Channels (Potassium Channel)IBA 12/2019 - 06/2016
2	Prion ProteinsIBA 01/2013 - 02/2008
2	polyglutamineIBA 05/2008 - 01/2002
2	Protein Isoforms (Isoforms)IBA 12/2004 - 11/2002
1	Phenobarbital (Luminal)FDA Link 02/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Long Noncoding RNAIBA 07/2021
1	RNA (Ribonucleic Acid)IBA 07/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AutoantigensIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Viral AntigensIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	EpitopesIBA 01/2021
1	VaccinesIBA 01/2021
1	Arginine (L-Arginine)FDA Link 10/2020
1	Messenger RNA (mRNA)IBA 06/2020
1	CeramidesIBA 09/2017
1	Insulin (Novolin)FDA Link 05/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2016
1	UbiquitinIBA 02/2016
1	NucleophosminIBA 09/2015
1	BromidesIBA 09/2015
1	Biological ProductsIBA 09/2015
1	Pharmaceutical PreparationsIBA 06/2013
1	PrionsIBA 01/2013
1	Rab geranylgeranyltransferaseIBA 12/2011
1	Retinaldehyde (Retinal)IBA 12/2011
1	Oncogene Proteins (Oncogene Protein)IBA 02/2010
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2010
1	Nerve Growth Factor (NGF)IBA 03/2008
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2002

Therapy/Procedure

2	Therapeutics 02/2022 - 06/2020
1	Drug Therapy (Chemotherapy) 01/2021
1	Resuscitation 06/2013